These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38381003)

  • 61. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients.
    Saleh MM; Irshaid YM; Mustafa KN
    Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma.
    Imanishi H; Okamura N; Yagi M; Noro Y; Moriya Y; Nakamura T; Hayakawa A; Takeshima Y; Sakaeda T; Matsuo M; Okumura K
    J Hum Genet; 2007; 52(2):166-171. PubMed ID: 17180579
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
    Chiusolo P; Reddiconto G; Farina G; Mannocci A; Fiorini A; Palladino M; La Torre G; Fianchi L; Sorà F; Laurenti L; Leone G; Sica S
    Leuk Res; 2007 Dec; 31(12):1669-74. PubMed ID: 17512587
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The pharmacogenetics of methotrexate in inflammatory bowel disease.
    Herrlinger KR; Cummings JR; Barnardo MC; Schwab M; Ahmad T; Jewell DP
    Pharmacogenet Genomics; 2005 Oct; 15(10):705-11. PubMed ID: 16141796
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MTHFR C677T polymorphism: association with lymphoid neoplasm and effect on methotrexate therapy.
    Ayad MW; El Naggar AA; El Naggar M
    Eur J Haematol; 2014 Jul; 93(1):63-9. PubMed ID: 24592886
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia.
    Shen Y; Wang Z; Zhou F; Jin R
    Open Life Sci; 2021; 16(1):1203-1212. PubMed ID: 34761111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
    Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
    Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
    Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R
    Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children.
    Mosaad YM; Abousamra NK; Elashery R; Fawzy IM; Eldein OA; Sherief DM; El Azab HM
    Leuk Lymphoma; 2015; 56(9):2699-705. PubMed ID: 25629981
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methylene tetrahydrofolate reductase and methionine synthase gene polymorphisms as genetic determinants of pre-eclampsia.
    Osunkalu VO; Taiwo IA; Makwe CC; Quao RA
    Pregnancy Hypertens; 2020 Apr; 20():7-13. PubMed ID: 32120336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia.
    Kamel AM; Moussa HS; Ebid GT; Bu RR; Bhatia KG
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):96-105. PubMed ID: 19034339
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate.
    Cwiklinska M; Czogala M; Kwiecinska K; Madetko-Talowska A; Szafarz M; Pawinska K; Wieczorek A; Klekawka T; Rej M; Stepien K; Halubiec P; Lazarczyk A; Miklusiak K; Bik-Multanowski M; Balwierz W; Skoczen S
    Front Pediatr; 2020; 8():307. PubMed ID: 32612964
    [No Abstract]   [Full Text] [Related]  

  • 73. Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia.
    Kodidela S; Pradhan SC; Dubashi B; Basu D
    Eur J Clin Pharmacol; 2015 Nov; 71(11):1349-58. PubMed ID: 26335211
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of SNPs in genes involved in folate metabolism with the risk of congenital heart disease.
    Wang B; Liu M; Yan W; Mao J; Jiang D; Li H; Chen Y
    J Matern Fetal Neonatal Med; 2013 Dec; 26(18):1768-77. PubMed ID: 23701284
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
    Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis.
    Liu B; Liu G; Liu B; Guo Y; Peng N; Li T
    World J Surg Oncol; 2024 Jan; 22(1):19. PubMed ID: 38212758
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methylenetetrahydrofolate reductase C677T and methionine synthase A2756G polymorphisms influence on leukocyte genomic DNA methylation level.
    Weiner AS; Boyarskikh UA; Voronina EN; Mishukova OV; Filipenko ML
    Gene; 2014 Jan; 533(1):168-72. PubMed ID: 24103477
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.
    Chiusolo P; Giammarco S; Bellesi S; Metafuni E; Piccirillo N; De Ritis D; Marietti S; Federica S; Laurenti L; Fianchi L; Hohaus S; Giuseppe L; Sica S
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):691-6. PubMed ID: 21984221
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis.
    Zhao M; Liang L; Ji L; Chen D; Zhang Y; Zhu Y; Ongaro A
    Pharmacogenomics; 2016 Jun; 17(9):1005-17. PubMed ID: 27270164
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J; Kralovánszky J; Adleff V; Pap E; Németh K; Komlósi V; Kovács G
    Anticancer Res; 2008; 28(5B):3051-4. PubMed ID: 19031955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.